0001411920-16-000005.txt : 20161109 0001411920-16-000005.hdr.sgml : 20161109 20161109151755 ACCESSION NUMBER: 0001411920-16-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161109 DATE AS OF CHANGE: 20161109 EFFECTIVENESS DATE: 20161109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IRX Therapeutics, Inc. CENTRAL INDEX KEY: 0001411920 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-274149 FILM NUMBER: 161983895 BUSINESS ADDRESS: STREET 1: 654 MADISON AVENUE STREET 2: SUITE 1601 CITY: New York STATE: NY ZIP: 10065 BUSINESS PHONE: 212-582-1199 MAIL ADDRESS: STREET 1: 654 MADISON AVENUE STREET 2: SUITE 1601 CITY: New York STATE: NY ZIP: 10065 FORMER COMPANY: FORMER CONFORMED NAME: IRX Therapeutics Inc DATE OF NAME CHANGE: 20070910 D 1 primary_doc.xml X0707 D LIVE 0001411920 IRX Therapeutics, Inc. 654 MADISON AVENUE SUITE 1601 New York NY NEW YORK 10065 212-582-1199 DELAWARE IRX Therapeutics Inc Corporation true Jeffrey Hwang c/o IRX Therapeutics, Inc. 654 Madison Avenue, Suite 1601 New York NY NEW YORK 10065 Executive Officer Curtis P. Robb c/o IRX Therapeutics, Inc. 654 Madison Avenue, Suite 1601 New York NY NEW YORK 10065 Executive Officer Zygmund Roth c/o IRX Therapeutics, Inc. 654 Madison Avenue, Suite 1601 New York NY NEW YORK 10065 Executive Officer John W. Hadden II c/o IRX Therapeutics, Inc. 654 Madison Avenue, Suite 1601 New York NY NEW YORK 10065 Executive Officer Director David H. Deming c/o IRX Therapeutics, Inc. 654 Madison Avenue, Suite 1601 New York NY NEW YORK 10065 Director George P. Denny III c/o IRX Therapeutics, Inc. 654 Madison Avenue, Suite 1601 New York NY NEW YORK 10065 Director John D. Halpern c/o IRX Therapeutics, Inc. 654 Madison Avenue, Suite 1601 New York NY NEW YORK 10065 Director Ferid Murad c/o IRX Therapeutics, Inc. 654 Madison Avenue, Suite 1601 New York NY NEW YORK 10065 Director Lawrence M. Wolf c/o IRX Therapeutics, Inc. 654 Madison Avenue, Suite 1601 New York NY NEW YORK 10065 Director Charles R. Cherington c/o IRX Therapeutics, Inc. 654 Madison Avenue, Suite 1601 New York NY NEW YORK 10065 Director Biotechnology Decline to Disclose 06b false 2016-10-18 false true true false 0 8000000 6400000 1600000 false 4 0 0 0 true false IRX Therapeutics, Inc. Curtis P. Robb Curtis P. Robb Chief Financial Officer 2016-11-09